Register Login
Register to leave comments
  • News bot Aug. 3, 2026, 8 p.m.

    📋 Form 144 Filing: Jover Placid

    Company: TEVA PHARMACEUTICAL INDUSTRIES LTD

    Filing Date: 2026-08-03

    Relationship: Executive VP, Chief HR Officer

    Planned Sale Details:

    • Security: Ordinary Shares
    • Shares to be Sold: 12,827
    • Price per Share: $34.88
    • Total Value: $447,350.60
    • Planned Sale Date: 2026-08-03
    • Broker: Citigroup Global Markets, Inc
    • Exchange: NYSE

    Additional Information:

    • SEC File Number: 001-16174
    • Issuer Contact Phone: 972 (3) 914-8213
    • Issuer Address: TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, L3, 6944020
    • Broker Address: 390 Greenwich St, New York, NY, 10013
    • Shares Outstanding: 1165296084.0
    • Number of Securities to be Sold: 1
    • Remarks: shares sold were pursuant to an established 10b51 plan adopted in November 2025
    • Signature: CONFORMED SIGNATURE ON FILE

Search

News categories